Pay in 4 interest-free payments of $10.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Epub 2016 Nov 11
Formula: C20H13FO6
by using three different mouse and human islet in vivo-based models
Fenretinide (4-HPR) exerts not just acute but also long term antitumor activity in selected T-ALL cell lines
Epub 2011 Dec 9
PAI-039 - CAS# 393105-53-8 size:2mg solid Epub 2016 Nov 11PAI 039, CAS No. 393105 53 8, is a novel plasminogen activator inhibitor 1 (PAI 1) inhibitor. The pharmacokinetic profile of PAI 039 indicated an oral bioavailability of 43 + 15. 3% and a plasma half life of 6. 2 + 1. 3 h. PAI 039 is an orally active prothrombolytic drug that inhibits PAI 1 and accelerates fibrinolysis while maintaining normal coagulation in a model of coronary occlusion . PAI 039 exerts antithrombotic efficacy in rat models of
US$ 40.00
US$ 16.00
US$ 2562.00
US$ 1604.50
US$ 49.95
US$ 1536.50
US$ 16.00
US$ 1869.50
US$ 37.95
US$ 34.95